Altria CEO Won't Size 2027 Duty Drawback Benefit After Barclays Floats $500 Million To $1 Billion

Sal Mancuso rebuffed analysts on next year's export tax recovery, which has a Philip Morris contract deal still to come.

Share
Altria CEO Won't Size 2027 Duty Drawback Benefit After Barclays Floats $500 Million To $1 Billion

Altria CEO Sal Mancuso refused on the company's third-quarter earnings call Thursday to give any range for next year's duty drawback benefit, the tax recovery on exported product, after a Barclays analyst said the company is exiting the year at about $500 million annually.

A range Altria wouldn't give

The Barclays analyst asked whether the benefit could climb to $1 billion in 2027 or land nearer $700 million to $800 million, as the current program ramps and a contract manufacturing agreement with Philip Morris International kicks in.

Mancuso's answer: "No, we're not providing that range." He said the PMI agreement is not yet showing in results, that the impact "will happen next year," and that the volume builds over time. Altria "won't provide any further guidance on that," he said.

CFO Heather Newman told a Goldman Sachs analyst that the PMI agreement does not start until 2027. The step-up from the second to the third quarter, she said, comes from current contract manufacturing arrangements, and she expects the third and fourth quarters to be balanced. The Goldman analyst said Altria exported 10% of its cigarette volume in the third quarter.

Third quarter and the fourth-quarter path

A Stifel analyst cited a $124 million third-quarter revenue benefit from duty drawback and asked whether that level is a fair guide for the fourth quarter. Newman said expectations are unchanged: a balanced step-up across the second half. She noted a slight benefit in the second quarter from the timing of a federal excise tax credit that Altria also benefited from in the third.

Altria, which makes Marlboro cigarettes, Copenhagen and Skoal smokeless tobacco, on! nicotine pouches and NJOY e-vapor products, raised its full-year adjusted earnings guidance to $5.66 to $5.74 a share, growth of 4.5% to 6% from $5.42 in 2025. Adjusted earnings per share rose 4.8% in the third quarter. Altria's market value was $121.9 billion in Thursday morning trading.

Cigarette profit without the drawback

The Barclays analyst also pressed on profit: excluding duty drawback, he said, operating income on the core cigarette business was flat even though volumes beat expectations. He asked how Altria will grow cigarette profit as volume comparisons toughen.

Mancuso pointed to pricing, cost management and duty drawback, and to strong nine-month income, rather than laying out a specific plan. Smokeable adjusted operating income rose 3.9% to $3.1 billion in the third quarter and 4.1% to $8.8 billion for the first nine months, Newman said.

The PMI contract manufacturing agreement starts in 2027, and Mancuso has said Altria will give no further guidance on what it is worth.

Sources

More on Altria Group

All Altria Group (MO) coverage →